| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Endovia Health Sciences, Inc.
13G
EDVA · 84862C401
|
7.2% |
10/22/2026
Event 10/15/2026
|
|||
| C/M Capital Master Fund, LP | 7.2% | ||||
| C/M Capital Partners, LP | 7.2% | ||||
| Thomas Walsh | 7.2% | ||||
| Jonathan Juchno | 7.2% | ||||
|
Catheter Precision, Inc.
13G
VTAK · 74933X708
|
10.0% |
8/21/2026
Event 8/16/2026
|
|||
| C/M Capital Master Fund, LP | 5.5% | ||||
| WVP Emerging Manager Onshore Fund LLC | 5.5% | ||||
| C/M Capital Partners, LP | 10.0% | ||||
| Thomas Walsh | 10.0% | ||||
| Jonathan Juchno | 10.0% | ||||
|
Volato Group, Inc.
13G
SOAR · 74349W302
|
6.2% |
7/6/2026
Event 6/27/2026
|
|||
| C/M Capital Master Fund, LP | 6.2% | ||||
| C/M Capital Partners, LP | 6.2% | ||||
| Thomas Walsh | 6.2% | ||||
| Jonathan Juchno | 6.2% | ||||
|
Beeline Holdings, Inc.
13G
BLNE · 277802500
|
6.2% |
6/4/2026
Event 5/28/2026
|
|||
| C/M Capital Master Fund, LP | 3.4% | ||||
| Cavalry Fund I LP | 0.4% | ||||
| C/M Capital Partners, LP | 3.7% | ||||
| Cavalry Investment Fund, LP | 2.4% | ||||
| Cavalry Fund I Management LLC | 2.4% | ||||
| Thomas Walsh | 6.2% | ||||
| Jonathan Juchno | 3.7% | ||||
|
Catheter Precision, Inc.
13G/A
Amendment 1
VTAK · 74933X708
|
0% |
5/14/2026
Event 3/31/2026
|
|||
| C/M Capital Master Fund, LP | 0% | ||||
| WVP Emerging Manager Onshore Fund LLC | 0% | ||||
| C/M Capital Partners, LP | 0% | ||||
| Mercer Street Global Opportunity Fund, LLC | 0% | ||||
| Mercer Street Capital Partners, LLC | 0% | ||||
| Thomas Walsh | 0% | ||||
| Jonathan Juchno | 0% | ||||
|
Catheter Precision, Inc.
13G
VTAK · 74933X708
|
9.6% |
2/13/2026
Event 2/6/2026
|
|||
| C/M Capital Master Fund, LP | 3.9% | ||||
| WVP Emerging Manager Onshore Fund LLC | 2.6% | ||||
| C/M Capital Partners, LP | 6.4% | ||||
| Mercer Street Global Opportunity Fund, LLC | 3.2% | ||||
| Mercer Street Capital Partners, LLC | 3.2% | ||||
| Thomas Walsh | 6.4% | ||||
| Jonathan Juchno | 9.6% | ||||
|
Biodexa Pharmaceuticals Plc
13G/A
Amendment 1
BDRX · 59564R880
|
0% |
11/14/2025
Event 6/30/2025
|
|||
| Cavalry Fund I LP | 0% | ||||
| C/M Capital Partners, LP | 0% | ||||
| Cavalry Investment Fund, LP | 0% | ||||
| Cavalry Fund I Management LLC | 0% | ||||
| Mercer Street Global Opportunity Fund, LLC | 0% | ||||
| Mercer Street Capital Partners, LLC | 0% | ||||
| Thomas Walsh | 0% | ||||
| Jonathan Juchno | 0% | ||||
|
Forward Industries, Inc.
13G/A
Amendment 1
FWDI · 349862409
|
1.6% |
11/14/2025
Event 9/30/2025
|
|||
| C/M Capital Master Fund, LP | 0.4% | ||||
| C/M Capital Partners, LP | 1.6% | ||||
| Thomas Walsh | 1.6% | ||||
| Jonathan Juchno | 1.6% | ||||
|
Heritage Distilling Holding Company, Inc.
13G/A
Amendment 1
IPST · 42727R104
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| C/M Capital Master Fund, LP | 0% | ||||
| C/M Capital Partners, LP | 0% | ||||
| Thomas Walsh | 0% | ||||
| Jonathan Juchno | 0% | ||||
|
Auddia Inc.
13G/A
Amendment 1
AUUD · 05072K305
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Cavalry Fund I LP | 0% | ||||
| WVP Emerging Manager Onshore Fund LLC | 0% | ||||
| C/M Capital Partners, LP | 0% | ||||
| Cadence Hill Opportunity Fund, LP | 0% | ||||
| Cavalry Fund I Management LLC | 0% | ||||
| Thomas Walsh | 0% | ||||
| Jonathan Juchno | 0% | ||||
|
Salarius Pharmaceuticals, Inc.
13G
DCOY · 79400X503
|
0% |
10/14/2025
Event 10/7/2025
|
|||
| C/M Capital Master Fund, LP | 0% | ||||
| C/M Capital Partners, LP | 0% | ||||
| Thomas Walsh | 0% | ||||
| Jonathan Juchno | 0% | ||||
|
Auddia Inc.
13G
AUUD · 05072K305
|
5.4% |
8/7/2025
Event 8/6/2025
|
|||
| Cavalry Fund I LP | 3.0% | ||||
| WVP Emerging Manager Onshore Fund LLC | 1.2% | ||||
| C/M Capital Partners, LP | 4.2% | ||||
| Cadence Hill Opportunity Fund, LP | 1.2% | ||||
| Cavalry Fund I Management LLC | 1.2% | ||||
| Thomas Walsh | 5.4% | ||||
| Jonathan Juchno | 4.2% | ||||
|
Heritage Distilling Holding Company, Inc.
13G
IPST · 42727R104
|
9.2% |
7/31/2025
Event 7/28/2025
|
|||
| C/M Capital Master Fund, LP | 9.2% | ||||
| C/M Capital Partners, LP | 9.2% | ||||
| Thomas Walsh | 9.2% | ||||
| Jonathan Juchno | 9.2% | ||||
|
Forward Industries, Inc.
13G
FWDI · 349862409
|
9.3% |
7/28/2025
Event 7/24/2025
|
|||
| C/M Capital Master Fund, LP | 9.3% | ||||
| C/M Capital Partners, LP | 9.3% | ||||
| Thomas Walsh | 9.3% | ||||
| Jonathan Juchno | 9.3% | ||||
|
Biodexa Pharmaceuticals Plc
13G
BDRX · 59564R807
|
6.8% |
5/28/2025
Event 5/20/2025
|
|||
| Cavalry Fund I LP | 5.7% | ||||
| C/M Capital Partners, LP | 5.7% | ||||
| Cavalry Investment Fund LP | 0.3% | ||||
| Cavalry Fund I Management LLC | 0.3% | ||||
| Mercer Street Global Opportunity Fund, LLC | 1.1% | ||||
| Mercer Street Capital Partners, LLC | 1.1% | ||||
| Thomas Walsh | 6.0% | ||||
| Jonathan Juchno | 6.8% | ||||
|
Biodexa Pharmaceuticals Plc
13G
BDRX · 59564R807
|
0% |
2/18/2025
Event 2/10/2025
|
|||
| C/M Capital Master Fund, LP | 0% | ||||
| C/M Capital Partners, LP | 0% | ||||
| Thomas Walsh | 0% | ||||
| Jonathan Juchno | 0% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.